0 CHECKOUT

Ear Care in Japan

  • ID: 1268983
  • July 2013
  • Region: Japan
  • 30 pages
  • Euromonitor International

After Kobayashi Pharmaceutical Co Ltd launched Naripitan in 2006, sales of ear care demonstrated strong growth for three years, increasing at a CAGR of 292% between 2006 and 2009. This phenomenal growth was possible because Kobayashi Pharmaceutical Co Ltd widely promoted its products as the solution to the increasingly common condition of tinnitus during the initial launch of Naripitan during 2006, when sales of ear care products in Japan were almost negligible due to low consumer awareness...

The Ear Care in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Ear Care market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

Note: Product cover images may vary from those shown

EAR CARE IN JAPAN
Euromonitor International
July 2013

LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Ear Care: Value 2007-2012
Table 2 Sales of Ear Care: % Value Growth 2007-2012
Table 3 Ear Care Company Shares by Value 2008-2012
Table 4 Ear Care Brand Shares by Value 2009-2012
Table 5 Forecast Sales of Ear Care: Value 2012-2017
Table 6 Forecast Sales of Ear Care: % Value Growth 2012-2017
Kobayashi Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 1 Kobayashi Pharmaceutical Co Ltd: Key Facts
Summary 2 Kobayashi Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Kobayashi Pharmaceutical Co Ltd: Competitive Position 2012
Executive Summary
Consumer Health Declines Slightly in Value Sales
Moderate Level of Pollen Discourages Sales of Antihistamines/allergy Remedies
Taisho Pharmaceutical Co Ltd Maintains the Leading Position
Online Sales of OTC Medication Becomes Legal
Value Sales of OTC Medication Is Expected To See A Slight Decline
Key Trends and Developments
Online Sales of OTC Medication Becomes Legal
Demographic Change Negatively Affects Sales of OTC Medication
Consumers Look for Flexible and Value Added Services To Retailers
Moderate Level of Pollen Discourages Sales of Allergy Remedies
Exercise and Running Continue To Be Popularity Among Consumers
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Table 8 Life Expectancy at Birth 2007-2012
Market Data
Table 9 Sales of Consumer Health by Category: Value 2007-2012
Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
Table 11 Consumer Health Company Shares 2008-2012
Table 12 Consumer Health Brand Shares 2009-2012
Table 13 Penetration of Private Label by Category 2007-2012
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
Table 16 Forecast Sales of Consumer Health by Category: Value 2012-2017
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Consumer Health Registration
Consumer Health Advertising
Consumer Health Packaging
Consumer Health Distribution
Regulation of Japanese Traditional Herbal Remedies (kampo)
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 4 OTC: Switches 2010-2012
Definitions
Sources
Summary 5 Research Sources

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • L'Oréal Group
  • Firmenich SA
  • Tate & Lyle, PLC.
  • Procter & Gamble Co.
  • Aveda Corporation